Vivos Therapeutics Inc (VVOS) Live Share Price, Invest From India

Vivos Therapeutics Inc Stock Performance

as on October 20, 2025 at 8:39 pm IST

Day's Low
Day's High
$2.85
Day's Price Range
$2.99
$2.92
2.40%
Downside
2.40%
Upside
52 Week's Low
52 Week's High
$1.98
52-Week Price Range
$7.95
$2.92
32.19%
Downside
172.26%
Upside

Vivos Therapeutics Inc share price movements today

Previous Close: $2.90
Open: $2.94
Volume: 291.7K
Day's Low - High: $2.85 - $2.99
52 Week Low - High: $1.98 - $7.95

Vivos Therapeutics Inc Historical Returns

1 Month Return: -15.7 %
3 Month Return: -50.17 %
1 Year Return: + 8.61 %
3 Year Return: -84.11 %
5 Year Return: 0 %

Vivos Therapeutics Inc Stock Fundamentals & Key Indicators

Check Vivos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.8M

EPS (TTM)

-1.875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.82

Industry PE ratio

PEG Ratio

EBITDA

-13.5M

Revenue (TTM)

14.4M

Profit Margin

-99.50%

Return On Equity TTM

4268100.00%

Vivos Therapeutics Inc Stock Valuation

Track how Vivos Therapeutics Inc P/E has moved over time to understand its valuation trends.

Vivos Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-125.70x)

December 31, 2020

Industry (0.00x)

October 20, 2025

Today (-0.82x)

October 20, 2025

Highest (-0.35x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.82x

Vivos Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vivos Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Vivos Therapeutics Inc	BUY	$21.8M	NA	-0.82	-99.50%
Boston Scientific Corp.	BUY	$147.0B	164.36%	59.07	13.55%
Stryker Corporation	BUY	$143.1B	69.57%	49.53	12.25%
Abbott Laboratories	BUY	$223.7B	18.62%	16.13	31.88%
Medtronic Plc	BUY	$122.9B	-12.25%	26.46	13.63%

See all

Stock Returns calculator for Vivos Therapeutics Inc Stock including INR - Dollar returns

The Vivos Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Vivos Therapeutics Inc investment value today

Current value as on today

₹1,14,093

Returns

₹14,093

(+14.09%)

Returns from Vivos Therapeutics Inc Stock

₹9,363 (+9.36%)

Dollar Returns*

₹4,730 (+4.73%)

Analyst Recommendation on Vivos Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Vivos Therapeutics Inc. Average target price of $5.25

Vivos Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Vivos Therapeutics Inc.

What analysts predicted

44.38%UPSIDE

Target Price

$5.25

Current Price

$2.92

Analyzed by

8 Analysts

Target

$5.25

Vivos Therapeutics Inc target price $5.25, a slight upside of 44.38% compared to current price of $2.92. According to 8 analysts rating.

Vivos Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Vivos Therapeutics Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 20, 2025 to October 20, 2025

Change:100% versus previous 30 day period

Vivos Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	3	3	3	3	4	3	3	3	3
Gross Profit	2	2	1	1	1	2	2	2	1	2
Operating Income	-5	-4	-3	-4	-3	-1	-2	-2	-3	-4
EBITDA	-4	-4	-3	-4	-3	-1	-2	-2	-3	-4
Interest Expense	3	-	-	3	-	3	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-5	-2	-4	-3	-1	-2	-2	-3	-5
Income Tax Expense	-6	0	-1	7	1	7	-2	-1	-	-
Net Income	4	-5	-2	-4	-3	-1	-2	-2	-3	-5
Net Profit Margin	123.77%	-162.83%	-63.41%	-131.13%	-110.06%	-47.61%	-67.77%	-76.45%	-128.12%	-131.23%

Vivos Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	3	11	13	16	16	13	15
Gross Profit	2	8	10	12	10	8	9
Operating Income	-8	-10	-8	-19	-25	-17	-11
EBITDA	-7	-9	-11	-19	-24	-16	-10
Interest Expense	0	0	0	0	1	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-8	-10	-12	-20	-23	-13	-11
Income Tax Expense	0	0	-3	0	-1	-	-
Net Income	-8	-10	-12	-20	-23	-13	-11
Net Profit Margin	-225.25%	-94.39%	-92.28%	-120.18%	-148.81%	-98.42%	-74.09%

Vivos Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-2	-4	-3	-1	-2	-2	-3	-5
Operating Cash Flow	-2	-2	-2	-2	-3	-4	-2	-3	-3
Investing Cash Flow	0	0	0	0	0	0	0	0	-5
Financing Cash Flow	-	-	3	3	7	3	3	-	11
Change in Cash	-3	-2	0	0	4	0	0	-3	2

Vivos Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-10	-12	-20	-23	-13	-11
Operating Cash Flow	-5	-5	-15	-19	-11	-12
Investing Cash Flow	0	0	-2	0	0	0
Financing Cash Flow	4	23	24	7	10	17
Change in Cash	0	17	5	-20	-1	4

Global Institutional Holdings in Vivos Therapeutics Inc

Funds	Holdings
UBS Group AG	1.9%
National Asset Management Inc	0.93%
Geode Capital Management, LLC	0.77%
Cutter & CO Brokerage, Inc.	0.65%
Vanguard Group Inc	0.57%

See all

Insights on Vivos Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 3.01M → 3.82M (in $), with an average increase of 21.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Boston Scientific Corp. has given 12.7% return, outperforming this stock by 4.1%
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 146.7% return, outperforming this stock by 230.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 5 quarters, -1.93M → -5.01M (in $), with an average decrease of 27.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, VVOS stock has moved down by -8.5%

About Vivos Therapeutics Inc

vivos therapeutics, inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (sdb) comprising mild-to-moderate obstructive sleep apnea (osa). the company's solutions cover proprietary alternatives for treating mild-to-moderate osa; craniofacial and anatomical anomalies that are associated with mild-to-moderate osa. its treatment for osa involves specially designed and customized oral appliances and treatment protocols. the company, through its vivos integrated healthcare network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate osa. vivos therapeutics, inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. it caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers,

Organisation	Vivos Therapeutics Inc
Headquarters	7921 Southpark Plaza, Littleton, CO, United States, 80120
CEO	Mr. R. Kirk Huntsman
E-voting on shares	Click here to vote

Key Management of Vivos Therapeutics Inc

Name	Title
Ms. RaeAnn Byrnes	Co-Founder and Senior VP of Events & Clinical Advisory Services
Mr. Nicholas M. DeGennaro	Senior Vice President of Mergers and Acquisition Group
Mr. John Ballard	Senior Vice President of Technology
Mr. Michael E. Bruhn	Executive VP of Business Operations Integration
Mr. R. Kirk Huntsman	Co-Founder, Chairman of the Board & CEO
Mr. Todd Huntsman	Co-Founder & Senior VP of Product and Technology
Ms. Susan McCullough	Co-Founder & Executive VP of Operations
Dr. Terry Jones	Senior VP of Human Resources
Ms. Ruth Hembree	Senior Vice President of Practice Services
Mr. Bradford K. Amman	CFO, Treasurer & Secretary

FAQs

What is Vivos Therapeutics Inc share price today?

Vivos Therapeutics Inc share price today is $2.92 as on October 20, 2025 at 8:39 pm IST. Vivos Therapeutics Inc share today touched a day high of $2.99 and a low of $2.85.

What is the 52 week high and 52 week low for Vivos Therapeutics Inc share?

Vivos Therapeutics Inc share touched a 52 week high of $7.95 on July 11, 2025 and a 52 week low of $1.98 on May 22, 2025. Vivos Therapeutics Inc stock price today i.e. October 20, 2025 at 8:39 pm IST is trending at $2.92,which is 63.27% down from its 52 week high and 47.47% up from its 52 week low.

What is Vivos Therapeutics Inc's market capitalisation today?

Vivos Therapeutics Inc market capitalisation is $0.00T as on October 20, 2025 at 8:39 pm IST.

How to invest in Vivos Therapeutics Inc Stock (VVOS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vivos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vivos Therapeutics Inc Shares that will get you 0.5137 shares as per Vivos Therapeutics Inc share price of $2.92 per share as on October 20, 2025 at 8:39 pm IST.

What is the minimum amount required to buy Vivos Therapeutics Inc Stock (VVOS) from India?

Indian investors can start investing in Vivos Therapeutics Inc (VVOS) shares with as little as ₹87.9 or $1 (as of October 20, 2025 at 8:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Vivos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 20, 2025 at 8:42 pm IST). Based on Vivos Therapeutics Inc share’s latest price of $2.92 as on October 20, 2025 at 8:39 pm IST, you will get 3.4247 shares of Vivos Therapeutics Inc. Learn more about fractional shares .